ENNOGEN INVESTMENTS LTD
ActiveKey figures
ENNOGEN INVESTMENTS LTD does not disclose its turnover in its latest accounts; the profit for the year is as stated in the accounts.
Ratios
2022Sector comparison
SIC 21100Where the company stands among the 1,055 active companies whose first SIC code is 21100 (Manufacture of basic pharmaceutical products).
- GE HEALTHCARE LIMITED£5.6bn
- THERMO FISHER SCIENTIFIC LIFE HOLDINGS LIMITED£1.4bn
- LRC PRODUCTS LIMITED£1bn
- SMITHKLINE BEECHAM LIMITED£940m
- DECHRA LIMITED£780.1m
- IPSEN BIOPHARM LIMITED£588.2m
- ORTHO-CLINICAL DIAGNOSTICS£295.7m
- BESPAK EUROPE LIMITED£256m
- SEQIRUS VACCINES LIMITED£254.2m
- IOVANCE BIOTHERAPEUTICS UK LTD£199.7m
Positions are approximate. Figures come from each company's latest accounts; money and employee figures are compared only with companies that filed accounts in pounds for a period ending in the last two and a half years and are not dormant. The line on each bar marks the median.
Summary: ENNOGEN INVESTMENTS LTD
What kind of company is it?
ENNOGEN INVESTMENTS LTD is a private limited company registered with Companies House under company number 13266253. It was incorporated on 15 Mar 2021. Its status is active. The registered office is in Dartford (DA1). Its nature of business (SIC 2007) is manufacture of basic pharmaceutical products (21100), wholesale of pharmaceutical goods (46460).
How is the company doing financially?
The latest accounts in the database are for 2022 (period ending 31 Dec 2022); the company files small company accounts (filleted). Loss for the year was £3,000. Net assets were £71,447,000. Total assets were £71,453,017 and total liabilities £6,017. The company had an average of 0 employees.
How does it compare with similar companies?
Compared with 1,055 active companies whose first SIC code is 21100: It is younger than 63% of them (median age 9.0 years).
Who runs and controls the company?
The company has 2 current directors. One person with significant control is registered. 2 of 4 registered charges are outstanding.
When are its next filings due?
The next accounts are due by 30 Sep 2027. The next confirmation statement is due by 28 Mar 2027.
Filed accounts2022
| 2022 | |
|---|---|
| Profit for the year | -3,000 |
| Total assets | 71,453,017 |
| Total liabilities | 6,017 |
| Net assets / total equity | 71,447,000 |
| Average number of employees | 0 |
A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.
History
8 events- Financial year endedAccounts filed at Companies House
- Financial year 2022 endedAccounts: net assets £71.4m, 0 employees
- Ennogen Holdings Limited registered as a person with significant control
- Mr Gurdev Singh Ruprai ceased to be a person with significant control
- Jason Rodney TATE appointedDirector
- Gurdev Singh RUPRAI appointedDirector
- Mr Gurdev Singh Ruprai registered as a person with significant control
- Company incorporatedPrivate limited company
Dates as recorded at Companies House: incorporation, name changes, officer appointments and resignations, current and former persons with significant control, and the end of each financial year with figures in the database.